1. Global Strategy for Asthma Management and Prevention. 2018[cited 2018 Aug 25]. Available from: https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-tracked_v1.3.pdfi 
2. Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24(1):14009. https://doi.org/10.1038/npjpcrm.2014.9 https://pubmed.ncbi.nlm.nih.gov/24921985 
3. Janežič A, Locatelli I, Kos M. 44th ESCP International Symposium on Clinical Pharmacy Medicines Information: Making Better Decisions : Lisbon, Portugal, 28-30 October 2015. Int J Clin Pharm. 2016;38(2):470-598. https://doi.org/10.1007/s11096-015-0240-y https://pubmed.ncbi.nlm.nih.gov/26739129 
4. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343-73. https://doi.org/10.1183/09031936.00202013 https://pubmed.ncbi.nlm.nih.gov/24337046 
5. Škrgat S, Triller N, Košnik M, Poplas Susič T, Petek D, Vodopivec Jamšek V, et al. Priporočila za obravnavo bolnika z astmo na primarni in specialistični pulmološki ravni v Sloveniji. Zdrav Vestn. 2016;85(11/12):693-706. https://doi.org/10.6016/ZdravVestn.2470 
6. Terl M, Sedlák V, Cap P, Dvořáková R, Kašák V, Kočí T, et al. Asthma management: A new phenotype-based approach using presence of eosinophilia and allergy. Allergy. 2017;72(9):1279-87. https://doi.org/10.1111/all.13165 https://pubmed.ncbi.nlm.nih.gov/28328094 
7. Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, et al. A new perspective on concepts of asthma severity and control. Eur Respir J. 2008;32(3):545-54. https://doi.org/10.1183/09031936.00155307 https://pubmed.ncbi.nlm.nih.gov/18757695 
8. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al.; GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med. 2004;170(8):836-44. https://doi.org/10.1164/rccm.200401-033OC https://pubmed.ncbi.nlm.nih.gov/15256389 
9. Demoly P, Annunziata K, Gubba E, Adamek L. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev. 2012;21(123):66-74. https://doi.org/10.1183/09059180.00008111 https://pubmed.ncbi.nlm.nih.gov/22379176 
10. Reddel HK, Jenkins CR, Marks GB, Ware SI, Xuan W, Salome CM, et al. Optimal asthma control, starting with high doses of inhaled budesonide. Eur Respir J. 2000;16(2):226-35. https://doi.org/10.1034/j.1399-3003.2000.16b08.x https://pubmed.ncbi.nlm.nih.gov/10968496 
11. Haughney J, Price D, Kaplan A, Chrystyn H, Horne R, May N, et al. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med. 2008;102(12):1681-93. https://doi.org/10.1016/j.rmed.2008.08.003 https://pubmed.ncbi.nlm.nih.gov/18815019 
12. Košnik M, Triller N, Šelb J. Mnenje pulmologov o pomenu vdihovalnikov pri bolnikih z astmo ali KOPB. Zdrav Vestn. 2017;86(3-4):105-14. https://doi.org/10.6016/ZdravVestn.2472 
13. Adeniyl FB, Young T. Weight loss intervention for chronic asthma. Cochrane Database Syst Rev. 2012;7:CD009339. https://doi.org/10.1002/14651858.CD009339.pub2 https://pubmed.ncbi.nlm.nih.gov/22786526 
14. Bousquet J, Schünemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, et al.; World Health Organization Collaborating Center for Asthma and Rhinitis. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol. 2012;130(5):1049-62. https://doi.org/10.1016/j.jaci.2012.07.053 https://pubmed.ncbi.nlm.nih.gov/23040884 
15. Sopo SM, Radzik D, Calvani M. Does treatment with proton pump inhibitors for GERD improve asthma symptoms in children with asthma and GERD? A systematic revie. J Investig Allergol Clin Immunol. 2009;19(1):1-5. https://pubmed.ncbi.nlm.nih.gov/19274922 
16. Meltzer EO, Busse WW, Wenzel SE, Belozeroff V, Weng HH, Feng J, et al. Use of the Asthma Control Questionnaire to predict future risk of asthma exacerbation. J Allergy Clin Immunol. 2011;127(1):167-72. https://doi.org/10.1016/j.jaci.2010.08.042 https://pubmed.ncbi.nlm.nih.gov/21093024 
17. Loymans RJ, Honkoop PJ, Termeer EH, Snoeck-Stroband JB, Assendelft WJ, Schermer TR, et al. Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model. Thorax. 2016;71(9):838-46. https://doi.org/10.1136/thoraxjnl-2015-208138 https://pubmed.ncbi.nlm.nih.gov/27044486 
18. Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2003(1):CD001117. https://pubmed.ncbi.nlm.nih.gov/12535399 
